Research Article

Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System

Figure 4

ATP, ADP, and AMP hydrolysis in synaptosomes from spinal cord (a) and cerebral cortex (b) of mice treated with uliginosin B (15 mg/kg, i.p.). Values are presented as means ± SEM (-6 mice/group). Specific enzyme activities were expressed as nmol Pi⋅min−1⋅mg−1 protein. compared to correspondent sham group; compared to correspondent vehicle group (ANOVA followed by Student-Newman-Keuls).
(a)
(b)